Overexpression of PEG10 in breast cancer cells is mediated by hyperactive status of receptor tyrosine kinases (RTKs), which are driven by external stimuli found within the tumor microenvironment, particularly transforming growth factor, activates RTKs and promotes the signaling cascade [29]. The gene discussed is PEG10; the disease is breast carcinoma.